Calidi, Biotherapeutics 15.02.2026 – 06:21:10 The completion of the strategic combination between First Light Acquisition Group…
Read More
Sonnet BioTherapeutics Adjourning Special Meeting to Increase Stockholder Participation in Business Combination with Hyperliquid Strategies Inc.
PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced…
Read More
